Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins
- PMID: 9840943
- DOI: 10.1038/sj.onc.1202505
Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins
Abstract
G1 cyclin E controls the initiation of DNA synthesis by activating CDK2, and abnormally high levels of cyclin E expression have frequently been observed in human cancers. We have isolated a novel human cyclin, cyclin E2, that contains significant homology to cyclin E. Cyclin E2 specifically interacts with CDK inhibitors of the CIP/KIP family and activates both CDK2 and CDK3. The expression of cyclin E2 mRNA oscillates periodically throughout the cell cycle, peaking at the G1/S transition, and exhibits a pattern of tissue specificity distinct from that of cyclin E1. Cyclin E2 encodes a short lived protein whose turnover is most likely governed by the proteasome pathway and is regulated by phosphorylation on a conserved Thr-392 residue. Expression of the viral E6 oncoprotein in normal human fibroblasts increases the steady state level of cyclin E2, but not cyclin E1, while expression of the E7 oncoprotein upregulates both. These data suggest that the expression of these two G1 E-type cyclins may be similarly regulated by the pRb function, but distinctly by the p53 activity.
Similar articles
-
Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.Oncogene. 2001 Jul 27;20(33):4554-67. doi: 10.1038/sj.onc.1204609. Oncogene. 2001. PMID: 11494151
-
Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.Exp Cell Res. 1995 Nov;221(1):92-102. doi: 10.1006/excr.1995.1356. Exp Cell Res. 1995. PMID: 7589260
-
Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.Oncogene. 1998 Feb 12;16(6):721-36. doi: 10.1038/sj.onc.1201793. Oncogene. 1998. PMID: 9488036
-
Cyclin E2, the cycle continues.Int J Biochem Cell Biol. 2002 Apr;34(4):315-20. doi: 10.1016/s1357-2725(01)00137-6. Int J Biochem Cell Biol. 2002. PMID: 11854029 Review.
-
Cyclin C makes an entry into the cell cycle.Dev Cell. 2004 May;6(5):607-8. doi: 10.1016/s1534-5807(04)00137-6. Dev Cell. 2004. PMID: 15130482 Review.
Cited by
-
Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.Front Endocrinol (Lausanne). 2024 Jun 10;15:1366290. doi: 10.3389/fendo.2024.1366290. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38915894 Free PMC article.
-
Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability.Front Cell Dev Biol. 2021 Nov 24;9:774845. doi: 10.3389/fcell.2021.774845. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34901021 Free PMC article. Review.
-
Joint changes in RNA, RNA polymerase II, and promoter activity through the cell cycle identify non-coding RNAs involved in proliferation.Sci Rep. 2021 Sep 23;11(1):18952. doi: 10.1038/s41598-021-97909-w. Sci Rep. 2021. PMID: 34556693 Free PMC article.
-
Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model.Sci Rep. 2021 Jul 21;11(1):14862. doi: 10.1038/s41598-021-94508-7. Sci Rep. 2021. PMID: 34290382 Free PMC article.
-
Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia.Leukemia. 2020 Jun;34(6):1626-1636. doi: 10.1038/s41375-019-0698-z. Epub 2020 Jan 6. Leukemia. 2020. PMID: 31908357 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous